Nurse Practitioner, Adult Health · Wilkes Barre, PA
NPI
1023028289
Since 2006
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
675 Baltimore Dr
Wilkes Barre, PA, 18702
Phone (570) 808-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
827 services
Medicare patients, 2024
392
Average age 71
Drug cost, 2024
$2.9M
5,337 prescriptions
Company payments, 2025
$13K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa Laporte was code 99214 (office e&m - established), 498 times for 321 patients. In total Melissa Laporte billed 827 services in 10 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 498 | 321 | $57.68 | $29K |
| 95251 Test - Miscellaneous | Office | 167 | 100 | $21.31 | $3,560 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 49 | 49 | $7.68 | $376 |
| 99215 Office E&M - Established | Office | 42 | 40 | $84.84 | $3,563 |
| 99213 Office E&M - Established | Office | 34 | 30 | $39.55 | $1,345 |
| 99204 Office E&M - New | Office | 20 | 20 | $71.47 | $1,429 |
By year: 2022 $30K for 549 services; 2023 $33K for 596 services; 2024 $40K for 827 services.
Medicare prescription drug claims, 2024
In 2024, the drug Melissa Laporte prescribed most often to Medicare patients was Ozempic (Semaglutide), with 470 prescriptions and refills. In total Melissa Laporte wrote 5,337 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 470 | 781 | 101 | $735K |
| Levothyroxine Sodium Generic | 443 | 1,077 | 128 | $5,613 |
| Jardiance Empagliflozin | 384 | 786 | 85 | $444K |
| Novolog Flexpen Insulin Aspart | 232 | 455 | 81 | $78K |
| Synthroid Levothyroxine Sodium | 205 | 442 | 50 | $17K |
| Metformin Hcl Generic | 184 | 533 | 62 | $1,820 |
| Metformin Hcl Er Metformin Hcl | 180 | 494 | 64 | $2,573 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 142 | 344 | 56 | $21K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 128 | 267 | 38 | $105K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 126 | 248 | 53 | $13K |
| Farxiga Dapagliflozin Propanediol | 125 | 217 | 27 | $118K |
| Trulicity Dulaglutide | 122 | 200 | 30 | $189K |
| Mounjaro Tirzepatide | 120 | 152 | 26 | $156K |
| Atorvastatin Calcium Generic | 119 | 353 | 39 | $1,963 |
| Glimepiride Generic | 96 | 271 | 35 | $1,020 |
Brand drugs: 3,035 claims; generic drugs: 1,755 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa Laporte $13K ($13K in general payments such as food, travel and fees) from 5 companies. The largest payer was Sanofi-Aventis U.S. LLC with $8,383.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.